209 related articles for article (PubMed ID: 29989354)
1. Increased Serpina3n release into circulation during glucocorticoid-mediated muscle atrophy.
Gueugneau M; d'Hose D; Barbé C; de Barsy M; Lause P; Maiter D; Bindels LB; Delzenne NM; Schaeffer L; Gangloff YG; Chambon C; Coudy-Gandilhon C; Béchet D; Thissen JP
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):929-946. PubMed ID: 29989354
[TBL] [Abstract][Full Text] [Related]
2. Muscle NAD
Hulmi JJ; Penna F; Pöllänen N; Nissinen TA; Hentilä J; Euro L; Lautaoja JH; Ballarò R; Soliymani R; Baumann M; Ritvos O; Pirinen E; Lalowski M
Mol Metab; 2020 Nov; 41():101046. PubMed ID: 32599075
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid-induced skeletal muscle atrophy.
Schakman O; Kalista S; Barbé C; Loumaye A; Thissen JP
Int J Biochem Cell Biol; 2013 Oct; 45(10):2163-72. PubMed ID: 23806868
[TBL] [Abstract][Full Text] [Related]
4. Detecting the Effects of the Glucocorticoid Dexamethasone on Primary Human Skeletal Muscle Cells-Differences to the Murine Cell Line.
Langendorf EK; Rommens PM; Drees P; Mattyasovszky SG; Ritz U
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260276
[TBL] [Abstract][Full Text] [Related]
5. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism.
Morgan SA; Hassan-Smith ZK; Doig CL; Sherlock M; Stewart PM; Lavery GG
J Endocrinol; 2016 Jun; 229(3):277-86. PubMed ID: 27048233
[TBL] [Abstract][Full Text] [Related]
7. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy.
Gilson H; Schakman O; Combaret L; Lause P; Grobet L; Attaix D; Ketelslegers JM; Thissen JP
Endocrinology; 2007 Jan; 148(1):452-60. PubMed ID: 17038559
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression.
Ma K; Mallidis C; Bhasin S; Mahabadi V; Artaza J; Gonzalez-Cadavid N; Arias J; Salehian B
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E363-71. PubMed ID: 12721153
[TBL] [Abstract][Full Text] [Related]
9. The effect of glutamine on prevention of glucocorticoid-induced skeletal muscle atrophy is associated with myostatin suppression.
Salehian B; Mahabadi V; Bilas J; Taylor WE; Ma K
Metabolism; 2006 Sep; 55(9):1239-47. PubMed ID: 16919545
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of muscle atrophy induced by glucocorticoids.
Schakman O; Gilson H; Kalista S; Thissen JP
Horm Res; 2009 Nov; 72 Suppl 1():36-41. PubMed ID: 19940494
[TBL] [Abstract][Full Text] [Related]
11. Lack of contribution of 11betaHSD1 and glucocorticoid action to reduced muscle mass associated with reduced growth hormone action.
Itoh E; Iida K; Kim DS; Del Rincon JP; Coschigano KT; Kopchick JJ; Thorner MO
Growth Horm IGF Res; 2004 Dec; 14(6):462-6. PubMed ID: 15519255
[TBL] [Abstract][Full Text] [Related]
12. FGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects of glucocorticoid on musculoskeletal degradation.
Adhikary S; Choudhary D; Tripathi AK; Karvande A; Ahmad N; Kothari P; Trivedi R
Life Sci; 2019 Jul; 229():261-276. PubMed ID: 31082400
[TBL] [Abstract][Full Text] [Related]
13. Genetic overexpression of Serpina3n attenuates muscular dystrophy in mice.
Tjondrokoesoemo A; Schips T; Kanisicak O; Sargent MA; Molkentin JD
Hum Mol Genet; 2016 Mar; 25(6):1192-202. PubMed ID: 26744329
[TBL] [Abstract][Full Text] [Related]
14. Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy.
Jones A; Hwang DJ; Narayanan R; Miller DD; Dalton JT
Endocrinology; 2010 Aug; 151(8):3706-19. PubMed ID: 20534726
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone-Induced Skeletal Muscle Atrophy Increases O-GlcNAcylation in C2C12 Cells.
Massaccesi L; Goi G; Tringali C; Barassi A; Venerando B; Papini N
J Cell Biochem; 2016 Aug; 117(8):1833-42. PubMed ID: 26728070
[TBL] [Abstract][Full Text] [Related]
16. Plasma proteome profiling of healthy subjects undergoing bed rest reveals unloading-dependent changes linked to muscle atrophy.
Murgia M; Brocca L; Monti E; Franchi MV; Zwiebel M; Steigerwald S; Giacomello E; Sartori R; Zampieri S; Capovilla G; Gasparini M; Biolo G; Sandri M; Mann M; Narici MV
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):439-451. PubMed ID: 36517414
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid aggravates bone micro-architecture deterioration and skeletal muscle atrophy in mice fed on high-fat diet.
Adhikary S; Kothari P; Choudhary D; Tripathi AK; Trivedi R
Steroids; 2019 Sep; 149():108416. PubMed ID: 31150681
[TBL] [Abstract][Full Text] [Related]
18. Regulation of CNS pathology by Serpina3n/SERPINA3: The knowns and the puzzles.
Zhu M; Lan Z; Park J; Gong S; Wang Y; Guo F
Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12980. PubMed ID: 38647003
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids Induce Bone and Muscle Atrophy by Tissue-Specific Mechanisms Upstream of E3 Ubiquitin Ligases.
Sato AY; Richardson D; Cregor M; Davis HM; Au ED; McAndrews K; Zimmers TA; Organ JM; Peacock M; Plotkin LI; Bellido T
Endocrinology; 2017 Mar; 158(3):664-677. PubMed ID: 28359087
[TBL] [Abstract][Full Text] [Related]
20. Acute In Vitro and In Vivo Effects of Dexamethasone in the Vocal Folds: a Pilot Study.
Gartling G; Nakamura R; Sayce L; Zimmerman Z; Slater A; Wilson A; Bing R; Branski RC; Rousseau B
Laryngoscope; 2023 Sep; 133(9):2264-2270. PubMed ID: 36317801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
